ELGX - Endologix Q4 revenue down 21% but above consensus; shares up 2% after hours February, 25 2019 04:27 PM Endologix Inc. Endologix (NASDAQ:ELGX) Q4 results (): Revenue: 34.7 (-21.1%). More news on: Endologix Inc, Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...